Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct neutralization profile of spike variants by antibodies induced upon SARS-CoV-2 infection or vaccination.

American journal of hematology·2021
Same author

Targeting the Interplay between HDACs and DNA Damage Repair for Myeloma Therapy.

International journal of molecular sciences·2021
Same author

Association Of -308G/A, -238G/A TNF-α Polymorphisms with Multiple Myeloma Risk and Survival: A Systematic Review and Meta-Analysis.

Clinical lymphoma, myeloma & leukemia·2021
Same author

Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients.

Prostate cancer and prostatic diseases·2021
Same author

Plasma Cell Leukemia - Facts and Controversies: More Questions than Answers?

Clinical hematology international·2021
Same author

FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology.

Blood advances·2021

Related Experiment Video

Updated: Jun 20, 2026

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

A new pet for myeloma.

Meletios-Athanassios Dimopoulos1, Lia A Moulopoulos, Evangelos Terpos

  • 1University of Athens.

Blood
|September 5, 2009
PubMed
Summary

The study shows that Fluorodeoxyglucose (FDG) suppression and PET/CT scans independently predict outcomes in newly diagnosed myeloma patients receiving the TT3 regimen before transplantation.

Area of Science:

  • Hematology
  • Oncology
  • Nuclear Medicine

Background:

  • Newly diagnosed myeloma patients often undergo treatment regimens prior to stem cell transplantation.
  • Positron Emission Tomography/Computed Tomography (PET/CT) imaging is utilized to assess disease burden and response.
  • Fluorodeoxyglucose (FDG) uptake on PET/CT can indicate metabolic activity of myeloma cells.

Discussion:

  • This study investigates the prognostic significance of pre-transplant PET/CT findings in multiple myeloma.
  • The research focuses on the predictive value of FDG suppression, a measure of treatment response, before transplantation.
  • The TT3 regimen is a specific treatment protocol used for newly diagnosed myeloma patients.

Key Insights:

  • The PET/CT scan results before transplantation hold independent predictive value for patient outcomes.

More Related Videos

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

Related Experiment Videos

Last Updated: Jun 20, 2026

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

  • Achieving FDG suppression prior to transplantation is also an independent predictor of success.
  • These findings highlight the importance of imaging and metabolic response assessment in treatment planning.

    • Outlook:

    • Further research may explore optimizing TT3 regimen duration based on PET/CT and FDG suppression.
    • These biomarkers could aid in stratifying patients for intensified or alternative treatment approaches.
    • The integration of imaging biomarkers may refine risk assessment and personalize therapy for myeloma.